Antibiotic News and Research

RSS
Anacor presents Phase 3 safety and efficacy results of Tavaborole for treatment of onychomycosis

Anacor presents Phase 3 safety and efficacy results of Tavaborole for treatment of onychomycosis

Kansas researchers defeat persistent bacteria known for causing infections in hospitals

Kansas researchers defeat persistent bacteria known for causing infections in hospitals

Human filariasis research: an interview with Professor Mark Taylor, Liverpool School of Tropical Medicine

Human filariasis research: an interview with Professor Mark Taylor, Liverpool School of Tropical Medicine

Chemical compound from ocean microbe offers potential treatments for anthrax

Chemical compound from ocean microbe offers potential treatments for anthrax

Sequella licenses Pfizer's exclusive worldwide rights to develop, commercialize sutezolid

Sequella licenses Pfizer's exclusive worldwide rights to develop, commercialize sutezolid

Cranberry consumption may prevent chronic infections

Cranberry consumption may prevent chronic infections

Researchers distinguish viral and bacterial infections in children with fever

Researchers distinguish viral and bacterial infections in children with fever

Infrared light allows characterization of pathogens

Infrared light allows characterization of pathogens

Chickens purchased from farmers markets carry higher bacterial loads

Chickens purchased from farmers markets carry higher bacterial loads

NPS MedicineWise calls on every Australian to fight against antibiotic resistance

NPS MedicineWise calls on every Australian to fight against antibiotic resistance

Scientists discover bacterium that stores biodegradable plastic

Scientists discover bacterium that stores biodegradable plastic

Curetis starts prospective clinical trial for Unyvero P50 pneumonia application

Curetis starts prospective clinical trial for Unyvero P50 pneumonia application

TGA of Australia approves Vertex Pharmaceuticals' KALYDECO for cystic fibrosis

TGA of Australia approves Vertex Pharmaceuticals' KALYDECO for cystic fibrosis

Infection control program and active surveillance can reduce incidence of impatient C. diff infections

Infection control program and active surveillance can reduce incidence of impatient C. diff infections

Soligenix announces personalized medicine collaboration with SciClone

Soligenix announces personalized medicine collaboration with SciClone

CorMedix's Neutrolin catheter lock solution receives CE Mark approval

CorMedix's Neutrolin catheter lock solution receives CE Mark approval

Immune response to TB bacterium varies between patients of different ethnic origin

Immune response to TB bacterium varies between patients of different ethnic origin

Saltwater-treatment for cystic fibrosis: an interview with Matthew Allen, Program Director at Cambridge Consultants

Saltwater-treatment for cystic fibrosis: an interview with Matthew Allen, Program Director at Cambridge Consultants

Research unravels a novel means of communication that allows bacteria to resist antibiotic treatment

Research unravels a novel means of communication that allows bacteria to resist antibiotic treatment

Scientists uncover easy strategies to prevent harmful side-effects of antibiotics responses

Scientists uncover easy strategies to prevent harmful side-effects of antibiotics responses

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.